PRESS RELEASE
News
-
-
-
PRESS RELEASE
EQS-Adhoc: Bondholders, minority shareholder and Management Board of ACCENTRO reach agreement in principle on comprehensive restructuring solution
ACCENTRO Real Estate AG and stakeholders agree on comprehensive restructuring solution, including bondholder agreement and equity restructuring plan -
PRESS RELEASE
EQS-Adhoc: Mynaric AG: Resignation of Bulent Altan as Chairman and Member of Supervisory Board
Mynaric AG announces resignation of Bulent Altan as Chairman and Member of Supervisory Board due to personal reasons, with new elections to follow. Company specializes in laser communication terminals for air, space, and mobile applications -
REGULATED PRESS RELEASE
Biophytis announces the settlement and delivery of its €2.6 million private placement
Biophytis announces the settlement and delivery of its €2.6 million private placement. New shares admitted for trading on Euronext Growth. Maxim Group LLC and Invest Securities involved in the transaction -
-
-
-
PRESS RELEASE
ALT5 Sigma Reports Strong Q4 and Full-Year 2024 Results, Achieves Milestones with Record Revenue, 1,000+ Customers, and Strategic Leadership Appointments
ALT5 Sigma Corp achieves record-breaking Q4 with $5.4 million revenue, surpasses 1,000 customer milestone, and appoints Ron Pitters as COO. Financial results and key developments highlighted -
PRESS RELEASE
Press Release: Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors
Qfitlia (fitusiran) approved as the first US therapy for hemophilia A or B with or without inhibitors, offering consistent protection with few injections, using unique mechanism to reduce bleeding episodes
